Substantial doubt about the company's ability to continue as a going concern.
“Bickford has been a cash basis tenant since 2022 when we received financial information from Bickford raising substantial doubt about its ability to continue as a going concern. As of June 30, 2026, these concerns had not been alleviated.”View the 10-Q filed Aug 10, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
On November 9, 2026, National Health Investors, Inc. entered indemnification agreements with each director and certain officer, including every executive officer, covering eligible expenses and liabilities to the maximum extent permitted by Maryland law.
National Health Investors cut 2026 guidance to $4.68 to $4.70 per share for NAIREIT and normalized NFFO and $236.6 million to $237.7 million for funds available for distribution, after third-quarter shop underperformance; investments are expected to total approximately $590 million.
National Health Investors reported $396.2 million of investment activity in 2026, with a portfolio mix of 77.4% leases and 15.7% SHOP, alongside a 6.9% WACY.
National Health Investors reported diluted net income of $11.47 per share for the quarter ended September 30, 2026, driven partly by a $541.6 million portfolio-sale gain; NAREIT FFO per diluted share rose 2.8% to $1.12.
National Health Investors sold 35 NHC-leased properties on July 1, 2026, recognizing $560.0 million cash consideration and a $541.6 million gain. Nine-month NOI rose to $243,523 from $223,892, and October acquisitions included six SHOs for $107.7 million.
